Drug Delivery Peptides
Drug Delivery Peptides represent a breakthrough class of biopharmaceutical carriers, cell-penetrating peptides (CPPs), and targeted ligand vectors designed to transport therapeutic payloads directly into targeted cellular compartments. By facilitating intracellular entry for nucleic acids, small molecules, proteins, and nanocarriers, these bioactive sequences dramatically enhance drug bioavailability, tissue specificity, and therapeutic efficacy while minimizing systemic toxicity. Pharmaceutical developers, clinical research organizations, and biotechnology buyers collaborate with specialized China factories featuring advanced solid-phase peptide synthesis (SPPS), high-performance liquid chromatography (HPLC) purification cascades, sterile freeze-drying infrastructure, and stringent cGMP quality management systems to produce high-purity drug delivery sequence conjugates.
Shanghai Sonyt Biotechnology Co., Ltd.
Shanghai Sonyt Biotechnology Co., Ltd. operates as a leading high-tech peptide synthesis factory based in China. The company runs state-of-the-art research laboratories and automated synthesis workshops equipped with multi-channel peptide synthesizers, preparative HPLC purification columns, industrial freeze-drying units, and comprehensive analytical testing centers (including LC-MS, HPLC, and MALDI-TOF analysis). Producing an extensive range of specialized bio-molecules-including cell-penetrating drug delivery peptides, target-homing ligands, lipopeptide conjugates, and modified carrier sequences-the enterprise supports research institutions and pharmaceutical clients across global markets.
Implementing strict quality control systems and multi-tier analytical validation, Shanghai Sonyt ensures high sequence fidelity, controlled endotoxin levels, and exceptional compound stability across every batch. Their specialized technical team provides tailored OEM/ODM contract synthesis, helping drug development partners with custom peptide modifications (PEGylation, fatty acid conjugation, fluorophore labeling, N-terminal/C-terminal capping), custom vial packaging, private labeling, and complete Certificates of Analysis (COA) documentation.
Supported by cold-chain logistics protocols and express global shipping capabilities, the factory provides fast, reliable supply chain execution to clinical laboratories, biotech enterprises, and pharmaceutical distributors across North America, Europe, and Asia-Pacific. Shanghai Sonyt Biotechnology Co., Ltd. remains a trusted wholesale production partner for custom drug delivery peptide sequences.
Shenzhen Hybio Pharmaceutical
Located in Shenzhen, Guangdong Province, Shenzhen Hybio Pharmaceutical operates cGMP-certified industrial peptide manufacturing bases in China. Equipped with large-capacity synthesis reactors and continuous purification facilities, the factory manufactures drug delivery peptide vectors, active pharmaceutical ingredients, and targeted peptide-drug conjugates for clinical developers worldwide.
HyBio Tech
Based in Wuhan, Hubei Province, HyBio Tech specializes in advanced bio-conjugation technologies, lipopeptide delivery systems, and custom peptide synthesis. The manufacturer combines automated solid-phase platforms with analytical testing laboratories, supplying custom cell-penetrating peptides and targeted carrier molecules to international biotechnology companies.
Chengdu Saint-Bio
Operating out of Chengdu, Sichuan Province, Chengdu Saint-Bio produces custom amino acid derivatives, peptide delivery polymers, and targeted sequence reagents in China. Utilizing specialized synthesis facilities and climate-controlled cleanrooms, the factory provides contract manufacturing, bulk synthesis, and OEM formulation for drug delivery researchers.
Hangzhou Peptide Biotech
Situated in Hangzhou, Zhejiang Province, Hangzhou Peptide Biotech manufactures high-purity research peptides, cyclic carriers, and specialized drug delivery ligands. Equipped with multi-column preparative HPLC systems and lyophilization suites, the enterprise delivers scale-up peptide synthesis and custom sequence production for pharmaceutical research supply chains.
